Beyond Medication Adherence: Unleashing the Power of Member Engagement to Elevate Outcomes
Leaders from CareFirst, CareSource, UPMC and Scene Health explore how proper medication adherence ensures a higher quality of life, improves health outcomes and reduces healthcare costs.
Many health plans saw their overall Medicare Star Ratings drop this year due to one particular area – medication adherence. Our expert panel from top-rated plans shares innovative and actionable strategies for overcoming barriers to medication adherence.
Topics for discussion include:
-
Reasons traditional approaches to medication adherence are not effective
-
Best ways to speed up intervention with a personalized, member-centric approach
-
Financial and ratings impacts of medication adherence measures
Confirmed Panelists
Tom Manetti, Associate Vice President, Quality Products, CareSource
Molly McGraw, PharmD, BCPS, Manager, Clinical Pharmacy, UPMC Health Plan
Suzanne Moxham, Director, Quality, Accreditation, & Government Programs at CareFirst BlueCross BlueShield
Sebastian Seiguer, CEO & Co-Founder, Scene Health
Connect with us on social media:
Facebook: facebook.com/brightspotshc
Instagram: https://www.instagram.com/brightspotshc/
LinkedIn: https://www.linkedin.com/company/shared-purpose-connect/
Twitter: https://twitter.com/BrightSpotsinHC
TikTok: https://www.tiktok.com/@brightspotshc
This episode is sponsored by Scene Health
Meet Scene Health, the medication engagement company that’s taking on the colossal $500 billion problem of medication nonadherence. But here’s the twist – they’re doing it in a novel way by leveraging asynchronous video engagement.
Scene’s model of care enhances the CDC-endorsed gold standard for ensuring medication adherence, Directly Observed Therapy. Their team of pharmacists, nurses, and health coaches engage with members via back-and-forth videos to build trust through person-to-person connections and empower every patient to take every dose of medication properly.
And they’re not just all talk. Scene Health has been clinically validated in 20 peer-reviewed publications and is already teaming up with Medicaid and Medicare health plans, public health departments, and life science organizations to tackle a range of conditions, from diabetes & asthma to sickle cell disease.
